Suppr超能文献

S100B 在轻度颅脑损伤管理中的临床验证。

Clinical validation of S100B use in management of mild head injury.

机构信息

Department of Paediatric Medicine, Halmstad Regional Hospital, Halmstad, Sweden.

出版信息

BMC Emerg Med. 2012 Oct 27;12:13. doi: 10.1186/1471-227X-12-13.

Abstract

BACKGROUND

Despite validated guidelines, management of mild head injury (MHI) is still associated with excessive computed tomography (CT) scanning. Reports concerning serum levels of S100B have shown promise concerning safe reduction in CT scanning but clinical validation and actual impact on patient management is unclear. In 2007, S100B was introduced into emergency department (ED) clinical management routines in Halmstad, Sweden. MHI patients with low (<0.10 mikrogram/L) levels of S100B could be discharged without CT. Our aim was to examine the clinical impact and performance of S100B in clinical use for MHI patients.

METHODS

Adult ([≥]18 years) patients with MHI (GCS 14-15, loss of consciousness and/or amnesia and no additional risk factors) and S100B sampling within 3 hours were prospectively included in this validation study. Patients were managed according to the adapted guidelines and management was documented. Outcome was determined with a questionnaire 3 months post-trauma and medical records to identify significant intracranial complications such as new neuroimaging, neurosurgery and/or death related to the trauma.

RESULTS

512 patients were included. 24 (4.7%) showed traumatic abnormalities on CT and 1 patient died (0.2%). 138 patients (27%) had normal S100B levels and 374 patients (73%) showed elevated S100B levels. No patients with a normal S100B level showed significant intracranial complication. 44 patients (32%) were managed with CT despite the guidelines recommending discharge (all these CT scans were normal) and 28 patients (7%) were discharged despite a CT recommendation (follow-up was normal in all these patients). S100B had a sensitivity of 100% (95% CI 83-100%) and a specificity of 28% (95% CI 24-33%) for significant intracranial complications.

CONCLUSION

The clinical use of S100B within our existing guidelines for management of MHI is safe and effective. Adult MHI patients, without additional risk factors and with normal S100B levels within 3 hours of injury, can safely be discharged from the hospital.

摘要

背景

尽管有经过验证的指南,但轻度头部损伤(MHI)的管理仍然与过度进行计算机断层扫描(CT)有关。有关 S100B 血清水平的报告显示出了安全减少 CT 扫描的希望,但对其临床验证和对患者管理的实际影响尚不清楚。2007 年,S100B 被引入瑞典哈尔姆斯塔德的急诊部门(ED)临床管理常规中。S100B 水平较低(<0.10 微克/升)的 MHI 患者可以在不进行 CT 的情况下出院。我们的目的是检查 S100B 在 MHI 患者临床应用中的临床影响和性能。

方法

这项验证研究前瞻性纳入了成人(>=18 岁)MHI(GCS 14-15、意识丧失和/或健忘症且无其他危险因素)患者,并在伤后 3 小时内进行 S100B 采样。患者根据改编的指南进行管理,并记录管理情况。通过创伤后 3 个月的问卷调查和病历确定结果,以确定与创伤相关的新的神经影像学、神经外科和/或死亡等有意义的颅内并发症。

结果

共纳入 512 例患者。24 例(4.7%)CT 显示创伤性异常,1 例患者死亡(0.2%)。138 例(27%)患者 S100B 水平正常,374 例(73%)患者 S100B 水平升高。S100B 水平正常的患者无一例出现有意义的颅内并发症。尽管指南建议出院,但仍有 44 例(32%)患者接受 CT 检查(所有这些 CT 扫描均正常),有 28 例(7%)患者尽管有 CT 检查建议但仍出院(所有这些患者的随访均正常)。S100B 对有意义的颅内并发症的敏感性为 100%(95%CI 83-100%),特异性为 28%(95%CI 24-33%)。

结论

在我们现有的 MHI 管理指南中使用 S100B 是安全有效的。无其他危险因素且伤后 3 小时内 S100B 水平正常的成年 MHI 患者可安全出院。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc4c/3527238/a9159af993b7/1471-227X-12-13-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验